Researchers at the Wyss Institute have identified vorinostat as a promising treatment for Rett Syndrome using an AI-driven drug discovery process and innovative disease modeling. The findings demonstrate disease-modifying abilities across multiple tissues, offering hope for a potentially curative treatment.
A new gene therapy delivery device called NANOSPRESSO could revolutionize how hospitals treat rare diseases by allowing them to create personalized nanomedicines in-house. This democratized approach to precision medicine could boost access to low-cost bespoke gene and RNA therapies, especially in low-resource settings.
Scientists developed a precise, cost-effective way to make chiral ketones for medicines, agrochemicals, and more using photocatalysis. This approach solves the challenge of reaching remote stereocenters in molecules, allowing for eco-friendly production of valuable chemicals.
Researchers argue that deliberate full extinction might be acceptable in rare cases, but only with careful consideration of ecological and moral implications. The study calls for robust ethical safeguards and inclusive decision-making frameworks to guide the use of genetic modification technologies.
Chinese researchers developed a groundbreaking 3D genome mapping technology that reveals how the 3D organization of plant genomes influences gene expression, especially in photosynthesis. The innovation provides a precise tool for understanding long-range chromatin interactions and their role in regulating biological processes.
A team of scientists from SR-Tiget has identified a unique window shortly after birth to deliver lentiviral vectors directly into the bloodstream, enabling gene transfer and long-term engraftment. This approach shows promise for treating some genetic blood disorders without stem cell transplantation or chemotherapy.
A new study reveals that DNA methylation mediates the transgenerational inheritance of acquired cold tolerance in rice, supporting Lamarck's theory. Researchers developed a novel breeding strategy to develop stress-resilient crops, offering a promising avenue to tackle agricultural challenges posed by global climate change.
A study at the University of Zurich tracks live cellular development and epigenetic changes over multiple generations, showing how stress induces heterogeneity and increases genetic complexity. This research may lead to better understanding of cancer cell diversity and develop more effective therapies.
Spearhead Bio's TAHITI technology enables seamless integration of genes into crops, promising faster and cleaner path to crop improvement. The startup aims to generate next-generation improved crops with desired traits, improving speed to market and consumer acceptance.
Researchers developed a novel protein, LSUBP, to enhance uranium extraction from seawater. The engineered protein achieves high adsorption capacity, offering a promising new material for effective uranium extraction.
Researchers have discovered RNA pseudouridine as a novel diagnostic target for colorectal cancer. The study found correlations between pseudouridine modifications and clinical markers, enabling potential non-invasive diagnosis. The findings provide a molecular framework for RNA epigenetics-based stratification and targeted interventions.
The European Commission has awarded €8 million to two projects, SUN-PERFORM and Solar to Butanol – S2B, to develop highly efficient bio-inspired technologies for renewable fuel production. These innovations target hard-to-electrify sectors like aviation and shipping, aiming to significantly reduce Europe's carbon emissions.
A new study from Umeå University reveals that trees' circadian clocks regulate growth and seasonal events. Adjusting clock-associated genes could help trees synchronize with changing climates, improving forestry management. The study also has implications for global vegetation models predicting forest growth and carbon storage.
Researchers at KAIST discovered that DDX54 is the master regulator hindering immunotherapy's effectiveness in lung cancer. Supressing DDX54 enhances immune cell infiltration into tumors and improves immunotherapy efficacy.
A team of scientists has created a new method to selectively modify specific proteins in complex biological environments. They achieved this using aptamers and deoxyoxanosine, allowing precise conjugation of desired sites on target proteins. This breakthrough technology has the potential to revolutionize cancer diagnosis and treatment.
Scientists developed a new technology to produce Cre-loxP organisms in a single step, reducing the need for crossbreeding and decreasing production time. The method involves introducing a TAx9 sequence to prevent Cre gene expression in E. coli bacteria, allowing for precise control and modification of gene expression.
Researchers at MIT successfully triggered a key enzyme in starfish egg cells using different patterns of light, prompting predictable movements and contractions. The study provides a new optical tool for controlling cell shape in its earliest developmental stages.
Researchers at Osaka Metropolitan University developed an engineered yeast that can produce record-high yields of D-lactic acid from methanol, a key compound used in biodegradable plastics and pharmaceuticals. The optimized yeast strain achieves a 1.5-fold boost in production compared to other methanol-based methods.
Research reveals that placental DNA methylation influences expression of genes associated with psychiatric disorders, suggesting genetic risk manifests during prenatal stage. The study identifies schizophrenia, bipolar disorder, and major depression disorder as most strongly linked conditions.
Researchers at UC Santa Cruz engineered cellular models of embryos using CRISPR technology, allowing them to study early developmental stages without experimenting with actual embryos. The team found that 80% of stem cells organized into embryo-like structures, showcasing a remarkable collective behavior and molecular composition.
Australian scientists engineer fish and flies to break down toxic methylmercury into a less harmful gas, offering a new solution to environmental pollution. The research could lead to the creation of wildlife that protects both human health and the environment.
Researchers at Rice University have discovered a new method for customizing engineered living materials (ELMs) by altering protein matrices. The study revealed that small genetic changes can significantly impact the behavior of these materials, making them ideal for applications like tissue engineering and drug delivery.
Researchers at U of T have developed a new platform called smol-seq that uses DNA sequencing to detect metabolites. This method enables the analysis of hundreds of metabolites simultaneously, making it faster and more precise than current methods.
Researchers at UCSF used CRISPR gene editing technology to transform ordinary white fat cells into 'beige' fat cells that voraciously consume calories to make heat. Implanted near tumors, these cells outcompeted cancer cells for nutrients, beating back five types of cancer in lab experiments.
Researchers at Washington State University have created genetically engineered mice with human-like short telomeres, enabling the study of cellular aging as it occurs in humans. The new mouse model, called HuT mice, has significant implications for anti-aging research and cancer treatment.
Researchers at McGill University discovered a novel brain mechanism that explains why bipolar patients alternate between mania and depression. A dopamine-based 'second brain clock' controls mood shifts, operating in tandem with the body's natural sleep-wake cycle.
A recent study identifies microRNA396 as a key regulator of shoot regeneration in tomatoes, revealing its role in genotype-dependent variability. Suppressing miR396 enhances shoot regeneration rates and boosts GROWTH-REGULATING FACTOR expression.
Researchers at UMass Amherst have developed a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. The therapy uses genetically engineered strains of Salmonella that can target tumors and control the release of cancer-fighting drugs inside cancer cells.
Kobe University researchers discovered three gene regulation design principles to improve yeast promoter performance, reducing leakiness and increasing productivity. The study's findings have potential applications in hospitals and can be used to produce multiple biologics with a single yeast strain.
Researchers at Johns Hopkins Medicine have discovered that excessive Gata4 protein accumulation in vascular smooth muscle cells contributes to aortic aneurysm vulnerability in Loeys-Dietz patients. The study's findings may help refine treatments for this genetic disorder, which affects connective tissue systems.
Dr. Christopher Seet has received a $2.9 million R37 MERIT Award from the National Cancer Institute to develop innovative T cell therapies for cancer. The grant will support research into iPSC-derived T cells, which can be engineered for enhanced tumor-fighting capabilities.
Researchers developed a new tool called SigRM to analyze single-cell epitranscriptomics data, enabling the study of RNA modifications in individual cells. This can provide valuable insights into gene regulation and its impact on health and disease, particularly in complex conditions like cancer.
A team of scientists used CRISPR technology to investigate the role of Fel d 1, a gene that triggers cat allergies. By analyzing genetic diversity and expression levels, they found that cats genetically modified to lack CH2 were healthy, suggesting that the allergen may not be essential for feline health.
Knowing family health history is crucial for reducing heart attack and stroke risk. Experts recommend following Life's Essential 8 - five health behaviors and three health factors to lower genetic risks.
Researchers create system to manipulate cell behavior using 'crowd control' technique, enabling predictable patterns and structures. Cell density plays key role in guiding cellular development, offering potential for medical applications such as tissue engineering and organ regeneration.
Researchers achieved significant improvements in ethanol yields by genetically modifying cyanobacteria to optimize carbon flow and overexpress key enzymes. Modified strains produced ethanol at rates between 0.24 and 3.8 g/L, demonstrating robust performance improvements.
A new strategy for treating prostate cancer has been developed by blocking the GP130 signalling pathway, contrary to current medical understanding. The study found that activating GP130 in prostate cells reduces tumour growth and stimulates the immune system to fight cancer cells.
Scientists have developed novel magnetic nanodiscs that can remotely stimulate parts of the brain, potentially treating neurological and psychiatric conditions. The devices were injected into specific brain regions in mice and triggered by a weak electromagnet, demonstrating precise control over neural activity.
A team of scientists, led by Anne Bang, is working to establish clearer connections between genes and their effects on brain function and mental health. They will use high-throughput screening technology to study over 100 genes in brain cells.
Researchers are developing soybeans that can handle extreme weather conditions, allowing farmers to maintain yields under pressure. By studying plant adaptation strategies, scientists aim to create more resilient soybean varieties.
New research on genetically modified crops reveals potential environmental impacts, including increased pesticide use, deforestation, and greenhouse gas emissions. The study highlights the need for further research to support sustainable agriculture practices.
Researchers identified key control sites regulating gene expression in cells, including those controlling ancient viral sequences. Mutating these sites caused defects in cell differentiation and survival, as well as spurious activation of genes across the genome.
Scientists at Gladstone Institutes have discovered a diverse range of retrons that can edit DNA more quickly and efficiently than current methods, including CRISPR. The new retrons showed high editing rates in both bacteria and human cells, with some performing 10-fold better than the gold-standard retron.
Researchers at Boston University discovered a new method to harness self-amplifying RNA to create more effective vaccines. The modified saRNA vaccine protected mice from severe COVID-19 disease with a lower dose than current mRNA vaccines. Longer duration of protein expression and reduced inflammation were also observed.
Researchers at CABBI used genetic engineering to improve water use efficiency in climate-friendly C4 crops like sorghum and sugarcane, maximizing biomass production while minimizing water usage. The breakthrough could aid crops in mitigating drought stress and support the development of a sustainable bioeconomy.
Researchers engineered miniature linear and split-belt treadmills to study insect locomotion, gaining insights into proprioception's role in natural activities like walking. The study showed that flies can modify their steps to continue walking straight despite rotational perturbations.
A new vaccine created by Mizzou researchers protects cattle from bovine anaplasmosis, a devastating tick-borne disease causing hundreds of millions of dollars in economic losses. The vaccine has been proven to give immunized cattle protection for at least a month and is being discussed with industry partners for future distribution.
Researchers have developed two new methods to produce circular RNAs, which can silence genes and serve as templates for making therapeutic proteins. These circular RNAs display enhanced stability and biological activity in heart muscle cells and neurons.
Recent studies have demonstrated that dysregulation of m6A writers and erasers can significantly impact leukemia development and progression. The study found that targeting these modifications represents a promising therapeutic strategy for reducing proliferation and inducing apoptosis of leukemic cells.
Researchers at UMD developed a method to produce high-performance, structural wood without chemicals or energy-intensive processing. The engineered wood can resist deterioration, storing carbon for longer periods and reducing emissions.
Researchers genetically engineered Toxoplasma gondii to produce and release therapeutic proteins in the human brain, bypassing the blood-brain barrier. The method has potential implications for treating diseases caused by protein deficiencies or abnormal expression.
Researchers discovered a pheromone receptor that controls parenting behavior in African cichlid fish. The study found that males with a specific genetic mutation picked up eggs in their mouths, taking on the role of 'mouthbrooding' dads.
A new analysis found that people hospitalized for heart disease, stroke, or cardiovascular diseases are 83% more likely to be diagnosed with anxiety, depression, or other psychiatric conditions within the first year after hospitalization. Early mental health screening and intervention are crucial for patients and their loved ones.
Researchers engineered human skin bacteria to produce less lactic acid, attracting fewer mosquitoes to mice. The engineered microbes reduced mosquito attraction by up to 64.4% and also prevented bites.
Researchers have used CRISPR/Cas9 gene editing to improve groundcherry's growth habit and fruit characteristics. This breakthrough could lead to increased crop yields and reduce the need for pesticides. The study also highlights the potential of groundcherry as a model species for studying plant biology.
Researchers investigate chemical modifications to genetic regulation mechanisms, finding that Set8 controls gene activity through a mechanism other than histone modification. This study refines our understanding of genetic regulation relevant to human diseases like cancer.
Researchers have designed a novel Co-STAR receptor that combines genetic components of four types of immune cells to recognize and fight cancer cells. In laboratory studies, the Co-STAR receptor induced a sustained anti-tumor response against human cancer cells, leading to long-lasting remissions in mouse models.
Scientists have introduced a novel approach to recreate bacterial methylation patterns, enhancing DNA transformation. This enables the genetic modification of pathogenic bacteria and probiotics, leading to potential new antibiotics and cell-based therapies.
Researchers at VIB-UGent Center for Plant Systems Biology have developed a new method to improve maize transformation frequency using ternary vectors and morphogenic regulators. By combining these technologies, they achieved a 20-fold increase in transformed plants, paving the way for more effective research and innovative applications.
Researchers at the University of Sydney have developed SeekRNA, a programmable tool that can precisely target and relocate genetic sequences with high accuracy and flexibility. This breakthrough technology surpasses current limitations of CRISPR, enabling more precise editing and reducing errors.